X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
index medicus (11) 11
cytomegalovirus infections - immunology (8) 8
female (8) 8
human cytomegalovirus (8) 8
adult (7) 7
immunology (7) 7
middle aged (7) 7
preemptive therapy (7) 7
t cells (7) 7
aged (6) 6
cd4 antigen (6) 6
cytomegalovirus - immunology (6) 6
cytomegalovirus infections (6) 6
dendritic cells (6) 6
health aspects (6) 6
male (6) 6
simultaneous quantification (6) 6
transplantation (6) 6
cd4-positive t-lymphocytes - immunology (5) 5
cd8 antigen (5) 5
lymphocytes t (5) 5
t-cell response (5) 5
cd4-positive t-lymphocytes - virology (4) 4
cd8-positive t-lymphocytes - immunology (4) 4
cytomegalovirus (4) 4
immunity (4) 4
immunocompromised host (4) 4
infection (4) 4
infections (4) 4
lymphocytes (4) 4
patients (4) 4
pregnant women (4) 4
young adult (4) 4
adolescent (3) 3
antibodies (3) 3
cd4 (3) 3
cd8 (3) 3
cd8-positive t-lymphocytes - virology (3) 3
cmv infection (3) 3
cytokines (3) 3
deoxyribonucleic acid--dna (3) 3
enzyme-linked immunosorbent assay (3) 3
kidney transplantation (3) 3
kinetics (3) 3
organ transplant recipients (3) 3
pregnancy (3) 3
retrospective studies (3) 3
virology (3) 3
virus diseases (3) 3
-specific cd4 (2) 2
activation (2) 2
allergy and immunology (2) 2
antibody response (2) 2
astrocytoma - metabolism (2) 2
autografts (2) 2
blood (2) 2
bone-marrow-transplant (2) 2
brain neoplasms - metabolism (2) 2
cd4-positive t-lymphocytes - pathology (2) 2
cd8-positive t-lymphocytes - pathology (2) 2
cells, cultured (2) 2
child (2) 2
child, preschool (2) 2
cmv disease (2) 2
cytokine flow cytometry (2) 2
cytomegalovirus infections - diagnosis (2) 2
cytomegalovirus infections - prevention & control (2) 2
cytomegalovirus infections - virology (2) 2
deoxyribonucleic acid (2) 2
dna (2) 2
elispot (2) 2
enzyme-linked immunospot assay (2) 2
flow cytometry (2) 2
ganciclovir prophylaxis (2) 2
health risks (2) 2
heart transplantation (2) 2
hematology (2) 2
hematopoietic stem cell transplantation (2) 2
hematopoietic stem cells (2) 2
identify patients (2) 2
immune-responses (2) 2
immunocompromised patients (2) 2
immunoglobulin g (2) 2
immunohistochemistry (2) 2
infant (2) 2
infectious diseases (2) 2
kidney (2) 2
mediated-immunity (2) 2
medical research (2) 2
medicine (2) 2
medicine, experimental (2) 2
microbiology (2) 2
monoclonal-antibodies (2) 2
multidisciplinary sciences (2) 2
oncology (2) 2
organ transplantation - adverse effects (2) 2
organ-transplant recipients (2) 2
peptides (2) 2
predictive value of tests (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e41648
Journal Article
Journal Article
Journal Article
Immunology, ISSN 0019-2805, 08/2013, Volume 139, Issue 4, pp. 533 - 544
Journal Article
Journal of Clinical Virology, ISSN 1386-6532, 11/2019, Volume 120, pp. 38 - 43
Dating of primary human cytomegalovirus (HCMV) infection in pregnancy is crucial to define whether infection occurred before or during pregnancy and at which... 
Pregnancy | Dating of infection | IgG antibody | IgG avidity | IgM antibody | HCMV primary infection | ANTIBODIES | MANAGEMENT | VIROLOGY | PREVENTION | Cytomegalovirus infections | Pregnant women | Health aspects | Immunoglobulin G | Enzyme-linked immunosorbent assay
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 12/2015, Volume 21, Issue 12, p. 2192
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.bbmt.2015.08.002 
Antiviral agents | Stem cells | Cytomegalovirus infections | Transplantation | T cells | Health aspects | Hematopoietic stem cells | Infection control | Gastrointestinal diseases
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 12, pp. 2192 - 2202
Abstract The relative contribution of human cytomegalovirus (HMCV)–specific CD4+ and CD8+ T cells to the control of HCMV infection in hematopoietic stem cell... 
Hematology, Oncology and Palliative Medicine | CD8+ T cells | Hematopoietic stem cell transplantation | Human cytomegalovirus | Specific T cell immunity | CD4+ T cells | Gastrointestinal disease | CD4 | CD8 | Specific T cell immunity | T cells | (HCMV)-SPECIFIC CD4(+) | CD8(+) | DENDRITIC CELLS | PREEMPTIVE THERAPY | IMMUNOLOGY | BONE-MARROW-TRANSPLANT | VERSUS-HOST-DISEASE | TRANSPLANTATION | RESPONSES | CMV REACTIVATION | CD8(+) T cells | IDENTIFY PATIENTS | SIMULTANEOUS QUANTIFICATION | HEMATOLOGY | CD4(+) T cells | CD8-Positive T-Lymphocytes - pathology | Cell Proliferation | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Cytomegalovirus Infections - immunology | Hematologic Neoplasms - pathology | CD4-Positive T-Lymphocytes - pathology | Graft vs Host Disease - immunology | Transplantation, Homologous | Cytomegalovirus Infections - mortality | CD4-Positive T-Lymphocytes - immunology | Graft vs Host Disease - mortality | Adult | Female | Cytomegalovirus Infections - pathology | Retrospective Studies | CD4-Positive T-Lymphocytes - virology | Virus Activation | Cytomegalovirus - pathogenicity | Antiviral Agents - therapeutic use | Risk Factors | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Graft vs Host Disease - pathology | Cytomegalovirus - immunology | Graft vs Host Disease - drug therapy | CD8-Positive T-Lymphocytes - virology | Cytomegalovirus Infections - drug therapy | CD8-Positive T-Lymphocytes - drug effects | Survival Analysis | Hematologic Neoplasms - drug therapy | Aged | Hematologic Neoplasms - immunology | CD8-Positive T-Lymphocytes - immunology | Chronic Disease | CD4-Positive T-Lymphocytes - drug effects
Journal Article
Journal Article
Journal Article
Clinical Immunology, ISSN 1521-6616, 2009, Volume 131, Issue 3, pp. 395 - 403
Journal Article